Capella

Monthly Archives For: April 2012

April 29, 2012

Assessing Modeled CO2 Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants

C.Mundt et. al, ISRN Pediatrics.2012 April29; doi:10.5402/2012/721295.

Continue reading…

April 20, 2012

Positive Clinical Results for ALN-PCS, Reported at ATVB 2012

Yesterday, scientists presented positive results from our Phase I clinical trial of ALN-PCS at the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology 2012 Scientific Sessions held in Chicago. Results showed that administration of a single dose of ALN-PCS, in the absence of concomitant lipid-lowering agents such as statins, resulted in statistically significant and durable reductions of PCSK9 plasma levels of up to 84% and lowering of LDL-C of up to 50%.

View our  presentation (572 KB PDF) Read our press release (572 KB PDF)

Continue reading…

This part of our website contains archived information which should not be considered current and may no longer be accurate.